Treatment of Liver Fibrosis after Hepatitis B with TCM Combined with NAs Evaluated by Noninvasive Diagnostic Methods: A Retrospective Study

Table 5

Comparison of lymphocyte subpopulation between the two groups [ ± s].

	Cases	Treatments	CD3+ (%)	CD4+ (%)	CD8+ (%)	CD16+ (%)	CD19+ (%)
TCM users	24	Before	71.13 ± 11.71	44.03 ± 10.67	25.28 ± 8.70	16.15 ± 12.03	11.98 ± 5.39
		After	71.59 ± 9.68^△	42.61 ± 6.83^△	25.01 ± 8.22^△	19.44 ± 10.41	11.20 ± 4.12
TCM nonusers	29	Before	73.47 ± 9.65	49.20 ± 9.94	26.29 ± 8.03	18.64 ± 9.56	14.16 ± 6.56
		After	62.05 ± 10.7	38.29 ± 8.29	18.92 ± 5.64	17.72 ± 8.48	13.07 ± 4.55

Note. Compared with that before treatment in this group, ; compared with the TCM nonusers after treatment, ^△.